Table 1.
Global pooled prevalence of diabetes according to COVID-19 disease status
| COVID-19 case type | Pooled prevalence (95% CI) | No. of studies | No. of participants | I 2 | P heterogeneity | P Egger |
|---|---|---|---|---|---|---|
| Confirmed | 14.7% (12.5–16.9) | 100 | 24,475,042 | 1.000 | <0.01 | 0.123 |
| Nonhospitalized | 10.4% (7.6–13.6) | 34 | 1,305,952 | 0.994 | <0.01 | 0.650 |
| Hospitalized | 21.4% (20.4–22.5) | 513 | 3,319,738 | 0.998 | <0.01 | <0.01 |
| Nonsevere | 11.9% (10.2–13.7) | 101 | 62,832 | 0.968 | <0.01 | <0.01 |
| Severe | 28.9% (27.0–30.8) | 216 | 298,073 | 0.992 | <0.01 | <0.01 |
| Deceased | 34.6% (32.8–36.5) | 217 | 413,301 | 0.986 | <0.01 | 0.067 |